Early research (Phase 1)Study completedNCT07335198
What this trial is testing
Evaluate the Safety, Tolerability, Pharmacokinetics and Immunogenicity of Efimosfermin Alfa Administered as a Single Dose to Healthy Participants of Chinese, Japanese, and White/European Ancestry
Who this might be right for
Non-alcoholic Fatty Liver Disease
GlaxoSmithKline 30